)

Jaguar Health (JAGX) investor relations material
Jaguar Health Lytham Partners Fall 2025 Investor Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Key catalysts and inflection points
Recent and upcoming catalysts include FDA meetings, orphan drug applications, and new clinical data releases for crofelemer in cancer and rare diseases.
Crofelemer is FDA-approved for HIV-related chronic diarrhea and conditionally approved for chemotherapy-induced diarrhea in dogs.
Statistically significant results were achieved in breast cancer patients, leading to an orphan drug application for metastatic breast cancer.
Four phase 2 studies are ongoing in intestinal failure, with groundbreaking reductions in parenteral support for MVID and short bowel syndrome.
Expanded access programs and supplemental NDA filings are planned to expedite patient access.
Product pipeline and market opportunities
Crofelemer is positioned as a pipeline within a product, targeting multiple indications in both human and animal health.
The cancer therapy-related diarrhea market is analogous to the $4B chemotherapy-induced nausea market, with long-term therapy needs.
Short bowel syndrome represents a $4.5B market opportunity, with orphan designations in the US and Europe.
The veterinary market provides valuable commercialization insights and potential cross-market promotional support.
Business development efforts focus on non-dilutive partnerships, leveraging de-risked programs for larger deals.
Clinical and regulatory progress
Phase 3 trial in cancer therapy-related diarrhea completed; focus shifted to metastatic breast cancer for expedited approval.
Orphan drug application filed for metastatic breast cancer, with a treatment trial including all metastatic patients expected to complete in 2026.
Investigator-initiated trials in MVID and short bowel syndrome show unprecedented reductions in parenteral nutrition needs.
Upcoming FDA meetings aim to expedite approval for ultra-rare diseases with small patient populations.
Continued data presentations at major medical conferences are planned.
Next Jaguar Health earnings date

Next Jaguar Health earnings date

The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage